The community speaks

Every year, our program includes keynote speeches by some of the top thinkers and trend-makers in pharma, biotech, medtech, digital health, investment & funding, regulatory.

NLS Days features company presentations organised into tracks that interest specific audiences and fields, for example: pharma and biotechnology in R&D, therapeutics or diagnostics, academic and startup innovators, services providers.

Super Sessions address hot topics in science, business development and market strategies.

In between all of these delightful speaking events, we make sure everyone is refreshed by a classic Swedish ‘fika’ – all that your heart desires, plus lots of coffee.

Dr. Ulla Aapola

Project Leader, University of Tampere, Spark Finland

10 Sep 16:00 Exhibition Hall - Level 4 Academic Catwalk

Dr. Bertil Abrahamsson

Senior Principal Scientist, AstraZeneca

11 Sep 16:45 Room 35-36 Workshop 2 – The Innovative Medicine Initiative

Dr. Susanna Abrahmsén Alami

Principal Scientist - Drug Delivery, AstraZeneca

11 Sep 14:00 Room 35-36 Special Session – Nanomedicine

Dr. Magnus Aronsen

Project Leader, UiO, Spark Norway

10 Sep 16:00 Exhibition Hall - Level 4 Academic Catwalk

Dr. Ann Atlas

Senior Scientific Advisor Immuno-Oncology and Biomarker Lead, BMS

11 Sep 15:15 Plenary Room - Level 5 Super Session 4 – Precision Medicine

Mr. Kim Baden-Kristensen

Founder & CEO, Brain+

11 Sep 09:30 Plenary Room - Level 5 Super Session 1 – Financing

Mr. David Bejker

CEO, Affibody

12 Sep 11:15 Room 35-36 Workshop 4 – Intellectual Property

Dr. Sonia Benhamida

Senior Vice President Healthcare, DNB

11 Sep 09:30 Plenary Room - Level 5 Super Session 1 – Financing

Ms. Johanna Bergh

Partner and European Patent Attorney, AWA

Dr. Christel Bergström

Associate Professor, Uppsala University

11 Sep 16:45 Plenary Room - Level 5 Super Session 5 – Drug Delivery of the Future

Dr. Magnus Björsne

CEO, AstraZeneca BioVentureHub

11 Sep 14:00 Plenary Room - Level 5 Super Session 3 – Crossroads in BioPharma and HealthTech

Mr. Patrick Boisseau

Programme Manager on Nanomedicine, CEA-Leti

11 Sep 14:00 Room 35-36 Special Session – Nanomedicine

Dr. Martin Bonde

CEO, Vaccibody

12 Sep 11:15 Plenary Room - Level 5 Super Session 8 – Catching the Immuno-Oncology wave!

11 Sep 15:15 Room 35-36 Workshop 1 – Services Providers as Trusted Partners

Mr. Carsten Borring

Head of Listings & Capital Markets, Nasdaq

11 Sep 09:30 Plenary Room - Level 5 Super Session 1 – Financing

Dr. Filippo Bosco

Founder & CEO, BluSense Diagnostics

11 Sep 14:00 Room 35-36 Special Session – Nanomedicine

Dr. Mathieu Boudes

Public/Private Partnership Coordinator, European Patients' Forum (EPF)

11 Sep 11:30 Plenary Room - Level 5 Super Session 2 – Return on Engagement

Ms. Catherine Brett

External Relations Manager, IMI Executive Office

11 Sep 16:45 Room 35-36 Workshop 2 – The Innovative Medicine Initiative

Assoc. Prof. Petter Brodin

Facility Director, SciLifeLab

12 Sep 11:15 Room 24-25 Workshop 3 – SciLifeLab – Emerging Technologies

Ms. Christina Busmalis

Director, Global Life Sciences at IBM Watson Health

12 Sep 14:00 Plenary Room - Level 5 Super Session 9 – Artificial Intelligence in Life Science

Ms. Magda Chlebus

Director Science Policy, EFPIA

11 Sep 16:45 Room 35-36 Workshop 2 – The Innovative Medicine Initiative

Mr. Stephan Christgau

Senior Partner, Novo Seeds

11 Sep 09:30 Plenary Room - Level 5 Super Session 1 – Financing

Dr. Scott Cuthill

Chief Business Officer, Valo Therapeutics

11 Sep 09:30 Plenary Room - Level 5 Super Session 1 – Financing

Prof. Mark Daly

Director, Institute for Molecular Medicine Finland (FIMM)

12 Sep 14:00 Plenary Room - Level 5 Super Session 9 – Artificial Intelligence in Life Science

Dr. Maureen Deehan

Head of Corporate Development & Strategy, Nordic Nanovector

11 Sep 14:00 Room 35-36 Special Session – Nanomedicine

Dr. Rupert Dixon

Senior Director - Principal Scientific Advisor, IQVIA

11 Sep 15:15 Room 35-36 Workshop 1 – Services Providers as Trusted Partners

Mr. Olivier Duchamp

Managing Director, NLSDays - VP BD & Promotion, SwedenBIO

12 Sep 15:30 Exhibition Hall - Level 4 Nordic Stars Awards & Closing Address

11 Sep 08:30 Plenary Room - Level 5 Opening Plenary

Dr. Charlotte Edenius

VP Clinical and Business Development, Gesynta Pharma

11 Sep 15:15 Room 35-36 Workshop 1 – Services Providers as Trusted Partners

Mr. Bengt Hedin

Formulation Scientist, APL

11 Sep 16:45 Plenary Room - Level 5 Super Session 5 – Drug Delivery of the Future

Dr. Jonas Ekstrand

Director General, SwedenBIO

12 Sep 15:30 Exhibition Hall - Level 4 Nordic Stars Awards & Closing Address

11 Sep 08:30 Plenary Room - Level 5 Opening Plenary

Dr. Emilio Erazo-Fischer

Associate Director of Global Oncology BD, Boehringer Ingelheim

12 Sep 11:15 Plenary Room - Level 5 Super Session 8 – Catching the Immuno-Oncology wave!

Dr. Elin Esbjörner

Associate Professor, Biophysical Chemistry and Biochemistry, Chalmers University

11 Sep 16:45 Plenary Room - Level 5 Super Session 5 – Drug Delivery of the Future

Ms. Ebba Fåhraeus

CEO, SmiLe Incubator

12 Sep 11:15 Room 35-36 Workshop 4 – Intellectual Property

Dr. Marc Gailhardou

Managing Director, MSD Nordics

11 Sep 11:30 Plenary Room - Level 5 Super Session 2 – Return on Engagement

Mr. Pierre Gareau

Business Development Manager, Servier CDMO

11 Sep 15:15 Room 35-36 Workshop 1 – Services Providers as Trusted Partners

Prof. Craig Garner

Berlin Institute of Health, Founder SPARK Berlin

10 Sep 16:00 Exhibition Hall - Level 4 Academic Catwalk

Ms. Jennifer Grönqvist

Business Advisor HealthTech Nordic, SSP

11 Sep 14:00 Plenary Room - Level 5 Super Session 3 – Crossroads in BioPharma and HealthTech

Dr. Gunnveig Grødeland

Project Leader, UiO, Spark Norway

10 Sep 16:00 Exhibition Hall - Level 4 Academic Catwalk

Ms. Charlotta Gummesson

CEO, Sahlgrenska Science Park

11 Sep 14:00 Plenary Room - Level 5 Super Session 3 – Crossroads in BioPharma and HealthTech

Dr. Sara Gunnerås

Editor, Precision Medicine – The Swedish Industry Guide 2018, SwedenBIO

11 Sep 15:15 Plenary Room - Level 5 Super Session 4 – Precision Medicine

Mr. Jacob Gunterberg

Partner, HealthCap

11 Sep 09:30 Plenary Room - Level 5 Super Session 1 – Financing

Prof. Per Hall

Professor, Karolinska Institutet

10 Sep 16:00 Exhibition Hall - Level 4 Academic Catwalk

Dr. Mats Hansen

CEO, Spago Nanomedical

11 Sep 14:00 Room 35-36 Special Session – Nanomedicine

Ms. Carolina Hawranek

Head of PR and Communications, Umeå Biotech Incubator

10 Sep 18:00 Exhibition Hall - Level 4 Startup Challenge @ NLSDays 2018

Prof. Klaus Hedman

Project Leader, University of Helsinki, Spark Finland

10 Sep 16:00 Exhibition Hall - Level 4 Academic Catwalk

Dr. Minna Hendolin

Senior Director Health & Wellbeing, Business Finland

12 Sep 14:00 Plenary Room - Level 5 Super Session 9 – Artificial Intelligence in Life Science

Mr. Hans Herklots

Managing Director, LifeSci Advisors

12 Sep 08:30 Plenary Room - Level 5 Super Session 6 – International Investors Pitching

Dr. Andreas Hugerth

Senior Product Development Manager, Ferring Pharmaceuticals

11 Sep 16:45 Plenary Room - Level 5 Super Session 5 – Drug Delivery of the Future

Ms. Daniela Ibis

CEO, Daniela Ibis

12 Sep 11:15 Room 35-36 Workshop 4 – Intellectual Property

Dr. Annika Jenmalm-Jensen

Infrastructure Director, SciLifeLab

12 Sep 11:15 Room 24-25 Workshop 3 – SciLifeLab – Emerging Technologies

Dr. Simon S. Jensen

CEO and Co-Founder, MonTa Biosciences

12 Sep 11:15 Plenary Room - Level 5 Super Session 8 – Catching the Immuno-Oncology wave!

Ms. Hanne-Damgaard Jensen

Founder & CEO, ROS Therapeutics

11 Sep 11:30 Plenary Room - Level 5 Super Session 2 – Return on Engagement

Ms. Louise Jonshammar

Attorney At Law, AWA

12 Sep 11:15 Room 35-36 Workshop 4 – Intellectual Property

Mr. Magnus Jörntén-Karlsson

Project Director, AstraZeneca R&D

11 Sep 14:00 Plenary Room - Level 5 Super Session 3 – Crossroads in BioPharma and HealthTech

Dr. Stig Jørgensen

Program Director ReproUnion

12 Sep 09:45 Plenary Room - Level 5 Super Session 7 – Reproductive Medicine

Dr. Øyvind Kongstun-Arnesen

CEO, Ultimovacs

11 Sep 09:30 Plenary Room - Level 5 Super Session 1 – Financing

Prof. Mikael Kubista

CEO and Founder, TATAA BioCenter

11 Sep 16:45 Room 35-36 Workshop 2 – The Innovative Medicine Initiative

Ms. Oxana Kukhaneva

Venture Partner, Seventure Partners

12 Sep 08:30 Plenary Room - Level 5 Super Session 6 – International Investors Pitching

Dr. Shiva Kumar

VP & Chief Strategy Officer, IBM Watson

11 Sep 08:30 Plenary Room - Level 5 Opening Plenary

Mr. Johan Kördel

Senior Partner, Lundbeckfonden Ventures

12 Sep 08:30 Plenary Room - Level 5 Super Session 6 – International Investors Pitching

Dr. Ylva Trolle Lagerros

Associate Professor, Karolinska Institutet

10 Sep 16:00 Exhibition Hall - Level 4 Academic Catwalk

Prof. Ulf Landegren

Facility Director, SciLifeLab

12 Sep 11:15 Room 24-25 Workshop 3 – SciLifeLab – Emerging Technologies

Mr. Magnus Larsson

CEO, Promimic

11 Sep 14:00 Room 35-36 Special Session – Nanomedicine

Dr. Sara Lei

Clinical Advisor, Karolinska University Hospital

11 Sep 14:00 Plenary Room - Level 5 Super Session 3 – Crossroads in BioPharma and HealthTech

Dr. Lasse Leino

CEO, DelSiTech

11 Sep 16:45 Plenary Room - Level 5 Super Session 5 – Drug Delivery of the Future

Ms. Sandra Lindvall

Patent Attorney, Awapatent

Prof. Joakim Lundeberg

Facility Director, SciLifeLab

12 Sep 11:15 Room 24-25 Workshop 3 – SciLifeLab – Emerging Technologies

Assoc. Prof. Tomas Lundqvist

Senior Area Coordinator, RISE Research Institutes of Sweden

12 Sep 11:15 Room 24-25 Workshop 3 – SciLifeLab – Emerging Technologies

Mr. Anders Martin-Löf

CFO, Wilson Therapeutics

11 Sep 09:30 Plenary Room - Level 5 Super Session 1 – Financing

Mr. Niklas Mattsson

Partner and European Patent Attorney, AWA

12 Sep 11:15 Room 35-36 Workshop 4 – Intellectual Property

Dr. Helena Nord

Project Leader, SciLifeLab

11 Sep 15:15 Plenary Room - Level 5 Super Session 4 – Precision Medicine

Dr. Jenni Nordborg

Director & National Coordinator Life Sciences, The Government Offices - Head of Health Division, Vinnova

11 Sep 08:30 Plenary Room - Level 5 Opening Plenary

Dr. Ana Palma

Senior Director Global HTA & Patient Access Lead, Sobi

11 Sep 11:30 Plenary Room - Level 5 Super Session 2 – Return on Engagement

Dr. Holger Reithinger

Partner, Forbion

12 Sep 08:30 Plenary Room - Level 5 Super Session 6 – International Investors Pitching

Dr. Agneta Richter-Dahlfors

CEO, EBBA Biotech

11 Sep 14:00 Room 35-36 Special Session – Nanomedicine

Dr. Sampo Sammalisto

Advisor HealthTech, Business Finland

12 Sep 14:00 Plenary Room - Level 5 Super Session 9 – Artificial Intelligence in Life Science

Dr. Gunnar Sandberg

Program Director, Vinnova

11 Sep 16:45 Room 35-36 Workshop 2 – The Innovative Medicine Initiative

Dr. Ulrica Sehlstedt

Partner, Arthur D. Little

11 Sep 15:15 Plenary Room - Level 5 Super Session 4 – Precision Medicine

Mr. Tero Sivola

CEO, BC Platforms

Dr. Eva Sjökvist-Saers

CEO & Managing Director, APL

11 Sep 16:45 Plenary Room - Level 5 Super Session 5 – Drug Delivery of the Future

Dr. Erica Sloan

Group Leader, Cancer & Neural-Immune Research Lab, Monash University

12 Sep 11:15 Plenary Room - Level 5 Super Session 8 – Catching the Immuno-Oncology wave!